Harnessing the power of NHS patient data
Our £6.7m in funding will allow Barts Life Sciences to use anonymous patient data to improve the prevention, diagnosis and treatment of diseases.
Our £6.7m in funding will allow Barts Life Sciences to use anonymous patient data to improve the prevention, diagnosis and treatment of diseases.
Researchers from Queen Mary University of London launch a study to better understand the link between air pollution and increased risk of developing Covid-19.
Using our funding, researchers from Queen Mary University of London have launched a new clinical trial to investigate whether taking vitamin D could protect people from Covid-19.
For people with cardiovascular disease, heart attacks are more common in the morning. Our funding has helped researchers at Queen Mary University of London to understand why.
Researchers are using the latest 3D technology to look deeper inside cells to see how they are affected by disease and treatment.
Our funding is helping patients fully understand what they are agreeing to when they consent to undergoing a medical operation.
Our recently awarded grant will transform the Charterhouse Square campus at the Faculty of Medicine and Dentistry (FMD) at Queen Mary University of London.
We've given a £3m package of long-term support for the incredible staff at Barts Health NHS Trust who continue to go the extra mile to tackle Covid-19
31-year-old Beth was treated at three hospitals across Barts Health NHS Trust following a pulmonary embolism which left her close to death. She’s now looking for ways to give back to the hospitals, and to raise awareness of the condition.
Potentially revolutionary research into Parkinson's disease, multiple sclerosis and dementia is being undertaken at a centre created by our £1.5m grant.